Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for prevention of recurrence of superficial bladder tumor
ISRCTN65811336Phase 2Terminated
- Sponsor
- Leicester General Hospital
- Start
- Jun 2006
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in bladder cancer and transitional cell carcinoma (TCC) comparing Allopurinol with Placebo (2 arms). Started Jun 2006; status: terminated.
02
Drugs
allopurinol
03
Conditions
bladder cancertransitional cell carcinoma (TCC)
Beyond the preview
Go deeper on ISRCTN65811336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN65811336.